Navigation Links
China-Biotics, Inc. Reports Fourth Quarter and Full Year Fiscal 2008 Financial Results
Date:7/10/2008

of stores to 60 in Shanghai and five other cities in China

-- Joined International Probiotics Association

-- Launched new products such as Shining Probiotics Protein Powder

-- Signed contracts to supply probiotics to dairy and food manufacturers as additives

-- Launched new corporate and investor relations Web site

Fourth Quarter 2008 Results

During the fourth quarter of the 2008 fiscal year, net sales increased 51.5% to $12.7 million from $8.4 million a year ago. The increase primarily resulted from significant growth in the sales of new products, most of which were sold in the Company's Shining-branded retail outlets. The sales of new products accounted for 19% of total sales in the fourth quarter of 2008, compared to 3% in the same quarter the prior year.

"We concluded the 2008 fiscal year with a strong finish, continuing to achieve high growth in revenues and net income, as our combined strategy of company-owned retail stores and traditional sales through distributors was a great success," said Mr. Jinan Song, Chairman and Chief Executive Officer of China-Biotics. "We look forward to another promising fiscal year in 2009, as we remain on schedule to complete construction and begin production at our new bulk additives facility in the latter part of the 2008 calendar year. By then, we expect to become the dominant supplier of naturally occurring probiotic bacteria in China."

Gross profit for the quarter increased 40.7% to $8.4 million from $6.0 million a year ago. Gross margin was 66.4% in the fourth quarter, compared to 71.5% in the same period of fiscal 2007, as a 30% increase in pulp and paper costs resulted in greater packaging costs. The Company is working with suppliers of its packaging materials to bring down such costs in the future.

Operating expenses were $3.5 million, compared to $2.1 million in the fourth quarter of fiscal 2007. The increase was primarily due to setup and oper
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China-Biotics, Inc. to Present at Chinas 3rd Annual Food Safety Technology Forum 2008
2. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
3. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
4. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
5. China-Biotics, Inc. Completes Foundation for Its New Plant
6. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
7. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
8. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
9. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
10. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
11. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 The ... such as its definition, classification, application and ... specification, manufacturing process, and product cost structure. ... applications. The analysis also covers upstream raw ... industry development trend and proposals. In the ...
(Date:12/24/2014)... Dec. 23, 2014 China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... its majority-owned subsidiary, Shandong Taibang Biological Products Co. ... from the China Food and Drug Administration (the ... As previously disclosed in the Company,s public filings, ...
(Date:12/24/2014)... Fla. , Dec. 23, 2014  Rock Creek ... that it has filed a Clinical Trial Application (CTA) ... Healthcare products Regulatory Agency (MHRA) seeking regulatory approval to ... lead molecule, Anatabine Citrate. Contingent on the ... conduct a Phase I trial to assess the safety, ...
(Date:12/22/2014)... , Dec. 22, 2014 /PRNewswire/ - RepliCel Life Sciences ... medicine company focused on the development of autologous cell ... of the University of Calgary in conjunction with co-authors ... which further validates the company,s ongoing clinical research using ... of pattern baldness. The paper entitled " ...
Breaking Biology Technology:Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 2Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 3Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 4Newly Released Peer-Reviewed Publication Further Validates RepliCel's Use of Dermal Sheath Cup Cells to Treat Pattern Baldness 5
... , NATICK, Mass., Sept. 18 ... the completion of patient enrollment in the workhorse portion of ... controlled trial designed to support U.S. Food and Drug Administration ... approval of the platinum chromium PROMUS((R)) Element(TM) Everolimus-Eluting Coronary Stent ...
... , BASKING RIDGE, N.J., Sept. 17 ... antithrombotic aptamers with active control agents, announced today that the ... intent to grant a patent with claims directed to oligonucleotide ... This new patent grant in the Company,s portfolio extends the ...
... REYKJAVIK, Iceland, September 17 deCODE,genetics (Nasdaq: ... notice from the,Nasdaq Stock Market indicating that deCODE is not ... Rule") because the closing,bid price per share for its common ... days. In accordance with Nasdaq Listing Rules, deCODE,will be provided ...
Cached Biology Technology:Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 2Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 3Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent 4Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 2Regado Biosciences Announces Allowance in Europe of a Fundamental Patent Broadly Covering Oligonucleotide Modulators to Blood Coagulation Factor Aptamers 3deCODE Receives Nasdaq Bid Price Deficiency Notice 2deCODE Receives Nasdaq Bid Price Deficiency Notice 3
(Date:12/22/2014)... 22, 2014 Research and Markets ... addition of the "The Global Watermarking ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... overview of the global digital media watermarking ... and monitor piracy by securely and invisibly ...
(Date:12/19/2014)... 18, 2014 Research and Markets ( ... "Micro Market Monitor: North America Perimeter Security Systems Market" ... http://photos.prnewswire.com/prnh/20130307/600769 The North American perimeter ... of 3.6% from 2014 to 2019. Although the U.S. ... Canada is expected to grow at ...
(Date:12/17/2014)... , Dec. 15, 2014 Research and ... the addition of the "Samsung Galaxy S5 ... report to their offering. ... a totally different sensing technology than the iPhone ... fingerprint sensor in its product. The ...
Breaking Biology News(10 mins):The Global Watermarking and Fingerprinting Markets 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 2Micro Market Monitor: North America Perimeter Security Systems Market (Intrusion Detection Sensor, Video Surveillance, Communication/Alarm and Notification, Access Control System) 3Samsung Galaxy S5 - Home Button Synaptics Fingerprint Sensor Technology Analysis 2
... Society Explorer in Residence, called Her Deepness by the ... Living Legend by the Library of Congress, and first "Hero ... speaking at Northeastern University on May 22, 2013. Earle, a ... address to the College of Science,s Sustaining Coastal Cities Conference ...
... tropical waters during the winter breeding season, but they ... the year. NOAA researchers have provided the first ... on a feeding ground in the Northwest Atlantic. ... journal PLOS ONE , demonstrate the potential applications ...
... April 29, 2013 - Ontario Genomics Institute (OGI) ... Human Splicing Pipeline, which was recently purchased by ... In 2009, OGI invested in Cytognomix through its ... wealth of data generated by next-generation sequencing is ...
Cached Biology News:Oceanographer Sylvia Earle kicks off Northeastern's Sustaining Coastal Cities Conference 2Researchers track singing humpback whales on a Northwest Atlantic feeding ground 2OGI's investment in cytognomix contributes to the Shannon Human Splicing Pipeline's success 2
Chicken polyclonal to ytzF ( Abpromise for all tested applications). Antigen: Full length protein...
NEWBORN CALF SERUM AND PLASMA...
...
...
Biology Products: